MedTrace Logo

Oxford UKA and HTO Post-market Clinical Study

NCT04518111 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 370

Last updated 2024-05-23

No results posted yet for this study

Summary

The purpose of this study is to compare the performance and safety of medial UKA and HTO in the treatment of AMOA in term of functional outcome, radiographic assessment, range of motion, postoperative complications, revision rate and relevant health economics outcome.

Conditions

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Ye Huang · Beijing Chaoyang Emergency Medical Center

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-24
Primary Completion
2024-09-30
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04518111 on ClinicalTrials.gov